Emergent Biosolutions Inc

Healthcare · Drug Manufacturers - Specialty & Generic

6.80$ -3.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Emergent Biosolutions Inc (EBS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 743 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement EBS
Line item	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	45	79	56	83	131	153	183	179	235	286	273	282	313	404	489	489	561	782	1,106	1,577	1,774	1,118	1,049	1,044	743
Cost of Revenue	424	25	–	30	32	24	40	34	46	47	42	169	182	207	217	244	277	462	623	714	980	645	689	668	392
Gross Profit	-379	54	56	53	99	129	143	144	189	239	231	113	131	198	272	245	284	320	483	863	793	473	360	375	351
Research & Development	193	2.8	–	10	18	46	54	59	75	89	125	130	120	105	119	107	97	143	226	238	235	188	111	71	54
Selling, General & Administrative	–	–	–	40	61	90	56	55	74	76	74	76	88	123	148	144	143	203	274	303	348	340	373	308	186
Total Operating Expenses	870	16	–	40	51	90	110	115	148	166	199	81	88	109	131	139	159	231	369	425	452	643	1,086	484	240
Operating Income	-0.4	38	56	17	21	38	33	30	40	74	32	37	43	89	142	106	124	90	114	439	341	-170	-726	-109	110
Interest Expense	37	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.2	6.5	7.6	6.6	9.9	38	31	35	37	88	71	59
Pre-Tax Income	-0.6	37	–	17	21	38	36	33	42	73	32	32	43	84	136	99	119	82	77	412	303	-219	-731	-143	83
Income Tax Expense	2.1	0.7	-4.5	5.1	5.3	15	13	12	15	26	16	14	13	30	44	37	36	19	23	106	84	-7.4	29	48	30
Net Income	-0.6	36	4.5	11	16	23	23	21	31	52	23	24	31	37	63	52	83	63	55	306	220	-212	-761	-191	53
EBITDA	45	38	56	19	25	44	38	37	47	79	41	48	65	122	187	133	175	155	259	609	504	16	-47	53	240

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings